- Home
- WLGS vs EVOK Comparison
WLGS vs EVOK Comparison
Compare WLGS & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WLGS
- EVOK
- Stock Information
- Founded
- WLGS 1981
- EVOK 2007
- Country
- WLGS Hong Kong
- EVOK United States
- Employees
- WLGS N/A
- EVOK N/A
- Industry
- WLGS Engineering & Construction
- EVOK Biotechnology: Pharmaceutical Preparations
- Sector
- WLGS Consumer Discretionary
- EVOK Health Care
- Exchange
- WLGS Nasdaq
- EVOK Nasdaq
- Market Cap
- WLGS 4.4M
- EVOK 4.2M
- IPO Year
- WLGS 2023
- EVOK 2013
- Fundamental
- Price
- WLGS $0.04
- EVOK $5.05
- Analyst Decision
- WLGS
- EVOK
- Analyst Count
- WLGS 0
- EVOK 0
- Target Price
- WLGS N/A
- EVOK N/A
- AVG Volume (30 Days)
- WLGS 65.2M
- EVOK 7.2M
- Earning Date
- WLGS 08-14-2025
- EVOK 08-12-2025
- Dividend Yield
- WLGS N/A
- EVOK N/A
- EPS Growth
- WLGS N/A
- EVOK N/A
- EPS
- WLGS N/A
- EVOK N/A
- Revenue
- WLGS $3,951,649.00
- EVOK $11,594,083.00
- Revenue This Year
- WLGS N/A
- EVOK $57.82
- Revenue Next Year
- WLGS N/A
- EVOK $59.12
- P/E Ratio
- WLGS N/A
- EVOK N/A
- Revenue Growth
- WLGS N/A
- EVOK 89.89
- 52 Week Low
- WLGS $0.03
- EVOK $1.94
- 52 Week High
- WLGS $9.66
- EVOK $12.32
- Technical
- Relative Strength Index (RSI)
- WLGS 31.65
- EVOK 63.11
- Support Level
- WLGS $0.04
- EVOK $5.74
- Resistance Level
- WLGS $0.08
- EVOK $9.88
- Average True Range (ATR)
- WLGS 0.01
- EVOK 0.56
- MACD
- WLGS 0.01
- EVOK 0.34
- Stochastic Oscillator
- WLGS 23.18
- EVOK 36.43
About WLGS Wang & Lee Group Inc.
WANG & LEE Group Inc operates as an investment holding company. The firm conducts its primary operations through its indirectly wholly owned subsidiary WANG and LEE CONTRACTING LIMITED. WLHK provides contract engineering, installation, and out-fitting of the following products and services: low voltage electrical systems, mechanical ventilation and air-conditioning systems (MVAC), fire safety systems, water supply and sewage disposal systems, and site project management.
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.